Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Parkinson Disease
Studies from P.A. Kempster et al have provided new data on Parkinson disease
November 19th, 2007
According to recent research published in the journal Brain, "Patients with Parkinson's disease who develop disabling levoclopa-induced motor fluctuations have a stronger therapeutic response than those who experience a more modest but stable response. A difference in the histopathological lesion between the two groups might be responsible." "Case records from 97 patients with pathologically proven Parkinson's disease were reviewed to determine the pattern of levodopa response. Pathological findings for fluctuating and non-fluctuating cases were compared. Patients with motor fluctuations had a younger age of onset and longer disease course (P < 0.001),...
Source: Pain & Central Nervous System Week (2007-11-19)
|
